Evidence map›Paper›PMID 38622164›Full record

ArticleScientific reports2024

Repurposing non-pharmacological interventions for Alzheimer's disease through link prediction on biomedical literature.

Yongkang Xiao, Yu Hou, Huixue Zhou, Gayo Diallo, Marcelo Fiszman, Julian Wolfson, Li Zhou, Halil Kilicoglu, You Chen, Chang Su and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. KnowNet: Guided Health Information Seeking from LLMs via Knowledge Graph IntegrationIEEE transactions on visualization and computer graphics · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Yongkang Xiao *Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
Yu Hou *Division of Computational Health Sciences, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
Huixue ZhouInstitute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
Gayo DialloINRIA SISTM, Team AHeaD - INSERM 1219 Bordeaux Population Health, University of Bordeaux, 33000, Bordeaux, France.
Marcelo FiszmanNITES - Núcleo de Inovação e Tecnologia Em Saúde, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Brazil.
Julian WolfsonDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Li ZhouDivision of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Halil KilicogluSchool of Information Sciences, University of Illinois Urbana-Champaign, Champaign, IL, USA.
You ChenDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Chang SuDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Hua XuSection of Biomedical Informatics and Data Science, School of Medicine, Yale University, New Haven, CT, USA.
William G MantyhDepartment of Neurology, University of Minnesota, Minneapolis, MN, USA.
Rui ZhangDivision of Computational Health Sciences, Department of Surgery, University of Minnesota, Minneapolis, MN, USA. zhan1386@umn.edu.
University of Minnesota · USBrigham and Women's Hospital · USPontifical Catholic University of Rio de Janeiro · BRUniversité de Bordeaux · FRUniversity of Illinois Urbana-Champaign · USVanderbilt University Medical Center · USWeill Cornell Medicine · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Detecting synergistic effects of pharmacological and non-pharmacological interventions for AD/ADRDR01AG078154 · NIA · UNIVERSITY OF MINNESOTA · PI HUA XU, RUI ZHANG · 2022 to 2026
$4.2M
Dementia prevalence, APOE, and blood-based biomarkers of AD in Native American communitiesR01AG080806 · NIA · UNIVERSITY OF MINNESOTA · PI William G Mantyh · 2022 to 2026
$3.7M
NCATS NIH HHS UL1 TR001863NIA NIH HHS R01 AG078154NIA NIH HHS R01 AG080806
6 · The paper itself

Abstract

Non-pharmaceutical interventions (NPI) have great potential to improve cognitive function but limited investigation to discover NPI repurposing for Alzheimer's Disease (AD). This is the first study to develop an innovative framework to extract and represent NPI information from biomedical literature in a knowledge graph (KG), and train link prediction models to repurpose novel NPIs for AD prevention. We constructed a comprehensive KG, called ADInt, by extracting NPI information from biomedical literature. We used the previously-created SuppKG and NPI lexicon to identify NPI entities. Four KG embedding models (i.e., TransE, RotatE, DistMult and ComplEX) and two novel graph convolutional network models (i.e., R-GCN and CompGCN) were trained and compared to learn the representation of ADInt. Models were evaluated and compared on two test sets (time slice and clinical trial ground truth) and the best performing model was used to predict novel NPIs for AD. Discovery patterns were applied to generate mechanistic pathways for high scoring candidates. The ADInt has 162,212 nodes and 1,017,284 edges. R-GCN performed best in time slice (MR = 5.2054, Hits@10 = 0.8496) and clinical trial ground truth (MR = 3.4996, Hits@10 = 0.9192) test sets. After evaluation by domain experts, 10 novel dietary supplements and 10 complementary and integrative health were proposed from the score table calculated by R-GCN. Among proposed novel NPIs, we found plausible mechanistic pathways for photodynamic therapy and Choerospondias axillaris to prevent AD, and validated psychotherapy and manual therapy techniques using real-world data analysis. The proposed framework shows potential for discovering new NPIs for AD prevention and understanding their mechanistic pathways.

Indexed as

Alzheimer DiseaseHumansLearning

Identifiers

PMID38622164
PMCPMC11018822
OpenAlexW4394807755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.